ORAI1 and cancer: Defective signaling mechanisms of the CRAC channel proteins (STIM1, Orai1) can lead to diseases such as severe combined immunodeficiency, thrombocytopenia, tubular aggregate myopathy, ectodermal dysplasia or cancer [11,15,16].